POTI', Francesco
 Distribuzione geografica
Continente #
NA - Nord America 2.095
EU - Europa 1.527
AS - Asia 874
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 7
SA - Sud America 6
Totale 4.518
Nazione #
US - Stati Uniti d'America 2.070
CN - Cina 459
IT - Italia 389
IE - Irlanda 315
SG - Singapore 313
SE - Svezia 237
FI - Finlandia 198
DE - Germania 140
UA - Ucraina 121
TR - Turchia 74
AT - Austria 35
CA - Canada 25
FR - Francia 18
GB - Regno Unito 18
BE - Belgio 15
CZ - Repubblica Ceca 12
IN - India 10
NL - Olanda 10
CI - Costa d'Avorio 8
EU - Europa 7
HK - Hong Kong 5
ID - Indonesia 5
CL - Cile 4
PL - Polonia 4
RO - Romania 4
BG - Bulgaria 3
ES - Italia 2
IR - Iran 2
KZ - Kazakistan 2
LT - Lituania 2
RU - Federazione Russa 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
BR - Brasile 1
CO - Colombia 1
GH - Ghana 1
GR - Grecia 1
HU - Ungheria 1
VN - Vietnam 1
Totale 4.518
Città #
Chandler 349
Dublin 315
Santa Clara 259
Singapore 255
Ann Arbor 145
Jacksonville 140
Ashburn 109
Dearborn 108
Beijing 100
Parma 99
Boardman 95
Houston 83
Princeton 73
New York 70
Izmir 67
Nanjing 63
Wilmington 52
Chicago 40
Shanghai 35
Vienna 32
Helsinki 31
San Mateo 31
Bremen 27
Nanchang 24
Des Moines 23
Toronto 21
Hebei 20
Milan 20
Rho 20
Shenyang 20
Jinan 19
Seattle 17
Brussels 15
Hefei 15
Jiaxing 15
Fremont 14
Changsha 12
Tianjin 12
Guangzhou 11
Kunming 11
Bologna 10
Brno 10
Fairfield 10
Modena 9
Abidjan 8
Washington 8
Zhengzhou 8
Chengdu 7
Grafing 7
Rockville 6
Düsseldorf 5
Faenza 5
Hangzhou 5
Jakarta 5
Marseille 5
Pune 5
Taiyuan 5
Woodbridge 5
Borås 4
Dallas 4
Frankfurt am Main 4
Istanbul 4
Los Angeles 4
Naples 4
Norwalk 4
Paris 4
Segrate 4
Verona 4
Vigevano 4
Amsterdam 3
Ancona 3
Bergamo 3
Casièr 3
Crotone 3
Edinburgh 3
Formigine 3
Fuzhou 3
Huizen 3
Kocaeli 3
Leawood 3
Leipzig 3
London 3
Munich 3
Ningbo 3
Ottawa 3
Piacenza 3
Pisa 3
Reggio Emilia 3
Rome 3
San Giuliano Milanese 3
Shaoxing 3
Sofia 3
Stuttgart 3
Almaty 2
Ardea 2
Augusta 2
Brescia 2
Brooklyn 2
Cagliari 2
Caorso 2
Totale 3.120
Nome #
Treatments for COVID-19: emerging drugs against the coronavirus 171
Abacavir, nevirapine, and ritonavir modulate intracellular calcium levels without affecting GHRH-mediated growth hormone secretion in somatotropic cells in vitro 156
Effects of the radiocontrast agent iodixanol on endothelial cell morphology and function. 115
Impact of S1P mimetics on mesenteric ischemia/reperfusion injury 112
CYCLOSPORINE A IMPAIRS THE REVERSE CHOLESTEROL TRANSPORT FROM MACROPHAGES IN VIVO BY REDUCING STEROL FECAL EXCRETION 97
HDL and reverse cholesterol transport in humans and animals: Lessons from pre-clinical models and clinical studies 97
A Short Term Administration of Cyclosporine A to Mice Inhibits the Reverse Cholesterol Transport from Macrophages 95
PCSK9 ablation attenuates Aβ pathology, neuroinflammation and cognitive dysfunctions in 5XFAD mice 94
EFFETTI DEI MEZZI DI CONTRASTO E DELLA N-ACETILCISTEINA SU MORFOLOGIA E FUNZIONE DELLE CELLULE ENDOTELIALI UMANE 86
Effetto degli agonisti LXR sul trasporto inverso del colesterolo in vivo 85
Critical and emerging topics in dietary carbohydrates and health 84
Polyphenol health effects on cardiovascular and neurodegenerative disorders: A review and meta-analysis 83
Identification of 4-amino-2-Pyridones as new potent PCSK9 inhibitors: From phenotypic hit discovery to in vivo tolerability 81
EFFECTS OF RADIOLOGY CONTRAST MEDIA ON CULTURED HUMAN ENDOTHELIAL CELL MORPHOLOGY AND FUNCTION AND PROTECTIVE ACTION OF N-ACETYLCYSTEIN AND ROSUVASTATIN 79
LA CICLOSPORINA A INIBISCE IL TRASPORTO INVERSO DEL COLESTEROLO NEI TOPI 77
'Spare' Luteinizing Hormone Receptors: Facts and Fiction 76
RUOLO DELLA SFINGOSINA 1-FOSFATO E DEL SUO RECETTORE S1P3 NEL TRASPORTO INVERSO DEL COLESTEROLO 75
Effetto della Ciclosporina A sul trasporto inverso del colesterolo in vivo 74
Cyclosporine A Impairs the Macrophage Reverse Cholesterol Transport in Mice by Reducing Sterol Fecal Excretion 74
Alcohol pattern consumption differently affects the efficiency of macrophage reverse cholesterol transport in vivo 72
CYCLOSPORINE A IMPAIRS THE REVERSE CHOLESTEROL TRANSPORT FROM MACROPHAGES IN VIVO BY REDUCING STEROL FECAL EXCRETION 69
The LXR agonist T0901317 promotes the reverse cholesterol transport frommacrophages by increasing plasma efflux potential 69
LA CICLOSPORINA A RIDUCE IL TRASPORTO INVERSO DEL COLESTEROLO NEI TOPI ATTRAVERSO L’INIBIZIONE DELL’ESCREZIONE FECALE 69
Cyclosporine A modulates the macrophage reverse cholesterol transport in vivo 68
A SHORT TERM ADMINISTRATION OF CYCLOSPORINE A IMPAIRS THE REVERSE CHOLESTEROL TRANSPORT FROM MACROPHAGES IN VIVO 68
Macrophage, But Not Systemic, Apolipoprotein E Is Necessary for Macrophage Reverse Cholesterol Transport In Vivo 68
Effect of LXR agonists on reverse cholesterol transport in vivo 67
Clusterin enhances AKT2-mediated motility of normal and cancer prostate cells through a PTEN and PHLPP1 circuit 67
Drug-drug interactions in polypharmacy patients: The impact of renal impairment 62
Macrophage, but not systemic, apolipoprotein E is necessary for macrophage reverse cholesterol transport in vivo 61
Dual effect of statins on ABCA1-mediated lipid efflux from macrophages and hepatic cells 61
The liver-X-receptor agonist T0901317 stimulates in vivo reverse cholesterol transport in mice 60
Impact of apolipoprotein E (apoE) deficiency on reverse cholesterol transport in vivo 60
Meccanismo di attivazione dell’ATP-binding cassette A1 da parte del cAMP 60
Biglycan and atherosclerosis: Lessons from high cardiovascular risk conditions 60
ROLE OF APOLIPOPROTEIN E IN THE REVERSE CHOLESTEROL TRANSPORT IN VIVO 58
IN VIVO TREATMENT WITH CYCLOSPORINE A INCREASES EFFLUX POTENTIAL OF MOUSE PLASMA VIA ATP-BINDING CASSETTE TRANSPORTER ABCA1 58
Pharmacogenetics of GPCR variants: FSH receptor and infertility treatment 58
TRASPORTO INVERSO DEL COLESTEROLO: FATTORI DETERMINANTI L’EFFICIENZA DEL PROCESSO 56
The in vivo stimulation of LXR promotes the reverse cholesterol transport in vivo by increasing the efflux potential of sera 55
Effect of the LXR agonist T0901317 on reverse cholesterol transport in vivo 53
Aortic Gene Expression Profiles Show How ApoA-I Levels Modulate Inflammation, Lysosomal Activity, and Sphingolipid Metabolism in Murine Atherosclerosis 52
Impact of dietary lipids on the reverse cholesterol transport: What we learned from animal studies 52
Pitavastatin effect on ATP binding cassette A1-mediated lipid efflux from macrophages: evidence for liver X receptor (LXR)-dependent and LXR-independent mechanisms of activation by cAMP 51
EFFECTS OF RADIOLOGY CONTRAST MEDIA ON CULTURED HUMAN ENDOTHELIAL CELL MORPHOLOGY AND FUNCTION AND PROTECTIVE ACTION OF N-ACETYLCYSTEIN AND ROSUVASTATIN 50
Inferring biallelism of two FSH receptor mutations associated with spontaneous ovarian hyperstimulation syndrome by evaluating FSH, LH and HCG cross-activity 49
The LXR agonist T0901317 increases the efflux potential of sera and promotes the reverse cholesterol transport in mice 48
Atheroprotective role of high-density lipoprotein (HDL)-associated sphingosine-1-phosphate (S1P) 48
Il cAMP attiva l’ATP-Binding Cassette A1 (ABCA1) attraverso un duplice meccanismo 47
Cholesteryl ester transfer protein expression partially attenuates the adverse effects of SR-BI receptor deficiency on cholesterol metabolism and atherosclerosis 47
La rosuvastatina promuove il trasporto inverso del colesterolo nei topi 47
In vivo stimulation of LXR increases the efflux potential of sera and promotes the reverse cholesterol transport 46
Sphingosine-1 phosphate induces cAMP/PKA-independent phosphorylation of the cAMP response element-binding protein (CREB) in granulosa cells 46
Sphingosine 1-Phosphate (S1P): a bridge between HDL, inflammation and atherosclerosis? 45
Elevating Endogenous Sphingosine-1-Phosphate (S1P) Levels Improves Endothelial Function and Ameliorates Atherosclerosis in Low Density Lipoprotein Receptor-Deficient (LDL-R-/-) Mice 45
Enhanced expression of the sphingosine-1-phosphate-receptor-3 causes acute myelogenous leukemia in mice 44
SKI-II - a sphingosine kinase 1 inhibitor - exacerbates atherosclerosisin low-density lipoprotein receptor-deficient (LDL-R-/-) mice on high cholesterol diet 40
Targeted invalidation of SR-B1 in macrophages reduces macrophage apoptosis and accelerates atherosclerosis 39
Sphingolipids and atherosclerosis: focus on Sphingosine 1-Phosphate (S1P) 38
Identification of sclerostin as a putative new myokine involved in the muscle-to-bone crosstalk 38
Apolipoprotein M and Sphingosine-1-Phosphate Receptor 1 Promote the Transendothelial Transport of High-Density Lipoprotein 38
Human LH and hCG stimulate differently the early signalling pathways but result in equal testosterone synthesis in mouse Leydig cells in vitro 37
Glycosylation pattern and in vitro bioactivity of reference follitropin alfa and biosimilars 36
KRP-203, sphingosine 1-phosphate receptor type 1 agonist, ameliorates atherosclerosis in LDL-R-/-mice 36
Effect of sphingosine 1-phosphate (S1P) receptor agonists FTY720 and CYM5442 on atherosclerosis development in LDL receptor deficient (LDL-R-/-) mice 35
High density lipoprotein (HDL)-associated sphingosine 1-phosphate (S1P) inhibits macrophage apoptosis by stimulating STAT3 activity and survivin expression 33
LH increases the response to FSH in granulosa-lutein cells from sub/poor-responder patients in vitro 32
Treatments for COVID-19: Emerging drugs against the coronavirus-reply 31
Sphingosine kinase inhibition exerts both pro- and anti-atherogenic effects in low-density lipoprotein receptor-deficient (LDL-R -/-) mice 31
Seizures of illicit substances for personal use in two Italian provinces: Analysis of trends by type and purity from 2008 to 2017 30
Osteocytes specific GSK3 inhibition affects in vitro osteogenic differentiation 30
COVID-19 … What are drugs and strategies now? 29
Molecular basis of androgen action on human sexual desire 28
The “hitchhiker’s guide to the galaxy” of endothelial dysfunction markers in human fertility 27
Gnrh antagonists produce differential modulation of the signaling pathways mediated by gnrh receptors 26
WISP-2 expression induced by Teriparatide treatment affects in vitro osteoblast differentiation and improves in vivo osteogenesis 24
Membrane Estrogen Receptor (GPER) and Follicle-Stimulating Hormone Receptor (FSHR) Heteromeric Complexes Promote Human Ovarian Follicle Survival 23
Sphingosine-1-phosphate receptor 3 regulates the transendothelial transport of high-density lipoproteins and low-density lipoproteins in opposite ways 14
Editorial: Pharmacology of endocrine related GPCRs 11
Sphingosine 1-phosphate receptor 1 signaling in macrophages reduces atherosclerosis in LDL receptor–deficient mice 2
Totale 4.615
Categoria #
all - tutte 19.289
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.289


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020293 0 0 0 0 0 0 86 22 61 52 33 39
2020/2021448 4 32 28 14 61 57 39 14 73 12 85 29
2021/2022399 21 15 16 9 25 18 65 54 20 27 6 123
2022/20231.260 140 100 79 114 131 147 13 89 380 14 41 12
2023/2024557 23 42 13 21 26 140 31 54 19 34 45 109
2024/2025781 46 88 115 126 185 210 11 0 0 0 0 0
Totale 4.615